Gastrointestinal Drug Market Size Was Valued at USD 53760 Million in 2023 and is Projected to Reach USD 87040 Million by 2032, Growing at a CAGR of 5.5% From 2024-2032.
A Gastrointestinal drug that is used for the functional disorders of the Gastrointestinal system like controlling and getting relief from gastric acidity, regulating gastrointestinal motility, Irritable bowel syndrome, Chronic bloating, diarrhea, water flow, and improving digestion.